Floatz logo

Ari-0001

Follicular Lymphoma

GUSTAVO SALGUEROCell therapyPhase 2Active
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
65/ 100

Competitive context

127 Active assets in the Follicular Lymphoma cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
Merck Sharp & Dohme LLC
Phase 4BB
(+)-VINCRISTINE
Merck Sharp & Dohme LLC
Phase 4BB
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Sun Yat-sen University
Phase 4BB
PREDNISONE TABLETS
Merck Sharp & Dohme LLC
Phase 4BB
Bendamustine
Merck Sharp & Dohme LLC
Phase 4BB

View all 50 →

Same molecule, other indications

Ari-0001 is also rated in:

diffuse large B-cell lymphomaDormant
B
Indicative ·
62 / 100
View asset →
Acute Lymphoblastic Leukemia ,LymphomasDormant
B
Indicative ·
60 / 100
View asset →
Primary Mediastinal B-cell Lymphoma (PMBCL)Dormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →